Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Appliances & Equipment
- Sub-Industry: N/A
- Symbol: NASDAQ:NVCN
- CUSIP: N/A
- Web: www.neovasc.com
- Market Cap: $113.61 million
- Outstanding Shares: 78,897,000
- 50 Day Moving Avg: $1.57
- 200 Day Moving Avg: $1.46
- 52 Week Range: $0.39 - $3.34
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -7.58
- P/E Growth: 0.00
- Annual Revenue: $8.99 million
- Price / Sales: 12.64
- Book Value: ($0.28) per share
- Price / Book: -5.14
- EBIDTA: ($24,550,000.00)
- Net Margins: -1,423.84%
- Return on Equity: -741.55%
- Return on Assets: -68.95%
- Current Ratio: 0.32%
- Quick Ratio: 0.31%
- Average Volume: 777,608 shs.
- Beta: -0.13
- Short Ratio: 2.4
Frequently Asked Questions for Neovasc Inc (US) (NASDAQ:NVCN)
What is Neovasc Inc (US)'s stock symbol?
Neovasc Inc (US) trades on the NASDAQ under the ticker symbol "NVCN."
How were Neovasc Inc (US)'s earnings last quarter?
Neovasc Inc (US) (NASDAQ:NVCN) released its quarterly earnings data on Tuesday, March, 29th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.04. The business earned $2.24 million during the quarter, compared to analyst estimates of $3.26 million. Neovasc Inc (US) had a negative net margin of 1,423.84% and a negative return on equity of 741.55%. View Neovasc Inc (US)'s Earnings History.
Where is Neovasc Inc (US)'s stock going? Where will Neovasc Inc (US)'s stock price be in 2017?
4 analysts have issued twelve-month target prices for Neovasc Inc (US)'s shares. Their predictions range from $4.00 to $10.00. On average, they anticipate Neovasc Inc (US)'s share price to reach $6.50 in the next year. View Analyst Ratings for Neovasc Inc (US).
Who are some of Neovasc Inc (US)'s key competitors?
Some companies that are related to Neovasc Inc (US) include Corindus Vascular Robotics (CVRS), AcelRx Pharmaceuticals (ACRX), IRIDEX (IRIX), Cogentix Medical (CGNT), T2 Biosystems (TTOO), Iradimed Corp (IRMD), Digirad (DRAD), Edap Tms SA (EDAP), Second Sight Medical Products (EYES), Electromed (ELMD), EnteroMedics (ETRM), Cesca Therapeutics (KOOL), Rewalk Robotics Ltd (RWLK), Lombard Medical (EVAR), Avinger (AVGR), PhotoMedex (PHMD), Sunshine Heart (SSH) and InspireMD (NSPR).
Who are Neovasc Inc (US)'s key executives?
Neovasc Inc (US)'s management team includes the folowing people:
- Paul L. Geyer, Independent Chairman of the Board
- Alexei J. Marko, Chief Executive Officer, Director
- Christopher Clark, Chief Financial Officer, Corporate Secretary
- Brian McPherson, Chief Operating Officer
- Vicki Lee Bebeau, Vice President - Clinical Affairs
- Randy Lane, Vice President - Research & Development
- Jane H. Hsiao Ph.D., Independent Director
- Douglas Glen Janzen, Independent Director
- William O'Neill, Independent Director
- Steven D. Rubin Esq.,J.D., Independent Director
Who owns Neovasc Inc (US) stock?
Neovasc Inc (US)'s stock is owned by many different of institutional and retail investors. Top institutional investors include West Family Investments Inc. (3.81%), Gagnon Securities LLC (3.65%), Gagnon Advisors LLC (1.53%), Bailard Inc. (0.72%), Iguana Healthcare Management LLC (0.42%) and Candriam Luxembourg S.C.A. (0.13%). View Institutional Ownership Trends for Neovasc Inc (US).
Who sold Neovasc Inc (US) stock? Who is selling Neovasc Inc (US) stock?
Who bought Neovasc Inc (US) stock? Who is buying Neovasc Inc (US) stock?
How do I buy Neovasc Inc (US) stock?
Shares of Neovasc Inc (US) can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Neovasc Inc (US)'s stock price today?
MarketBeat Community Rating for Neovasc Inc (US) (NASDAQ NVCN)MarketBeat's community ratings are surveys of what our community members think about Neovasc Inc (US) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Neovasc Inc (US) stock can currently be purchased for approximately $1.44.
Earnings History for Neovasc Inc (US) (NASDAQ:NVCN)Earnings History by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/14/2016||Q216||($0.06)||($0.12)||$2.20 million||$3.03 million||View||N/A|
|3/29/2016||Q415||($0.15)||($0.11)||$3.26 million||$2.24 million||View||N/A|
|11/9/2015||Q3 2015||($0.10)||($0.11)||$3.46 million||$2.48 million||View||N/A|
|8/6/2015||Q2 2015||($0.10)||($0.10)||$3.19 million||$2.93 million||View||N/A|
|5/12/2015||Q115||($0.05)||($0.08)||$3.84 million||$2.86 million||View||N/A|
|3/30/2015||Q414||($0.06)||($0.11)||$3.31 million||$3.35 million||View||N/A|
Earnings Estimates for Neovasc Inc (US) (NASDAQ:NVCN)
2017 EPS Consensus Estimate: ($0.12)
2018 EPS Consensus Estimate: ($0.04)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Neovasc Inc (US) (NASDAQ:NVCN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Neovasc Inc (US) (NASDAQ:NVCN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Neovasc Inc (US) (NASDAQ:NVCN)
Latest Headlines for Neovasc Inc (US) (NASDAQ:NVCN)
Neovasc Inc (US) (NVCN) Chart for Monday, May, 29, 2017